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Cheryl E Dunlop1, Evelyn E Telfer2 and Richard A Anderson1*Abstract
It has long been established that germline stem cells
(GSCs) are responsible for lifelong gametogenesis in
males, and some female invertebrates (for example,
Drosophila) and lower vertebrates (for example, teleost
fish and some prosimians) also appear to rely on GSCs
to replenish their oocyte reserve in adulthood.
However, the presence of such cells in the majority of
female mammals is controversial, and the idea of a
fixed ovarian reserve determined at birth is the
prevailing belief among reproductive biologists.
However, accumulating evidence demonstrates the
isolation and culture of putative GSCs from the ovaries
of adult mice and humans. Live offspring have been
reportedly produced from the culture of adult mouse
GSCs, and human GSCs formed primordial follicles
using a mouse xenograft model. If GSCs were present
in adult female ovaries, it could be postulated that the
occurrence of menopause is not due to the
exhaustion of a fixed supply of oocytes but instead is
a result of GSC and somatic cell aging. Alternatively,
they may be benign under normal physiological
conditions. If their existence were confirmed, female
GSCs could have many potential applications in both
basic science and clinical therapies. GSCs not only may
provide a valuable model for germ cell development
and maturation but may have a role in the field of
fertility preservation, with women potentially being
able to store GSCs or GSC-derived oocytes from their
own ovaries prior to infertility-inducing treatments.
Essential future work in this field will include further
independent corroboration of the existence of GSCs
in female mammals and the demonstration of the
production of mature competent oocytes from GSCs
cultured entirely in vitro.Critically, the physiological role of these cells in vivo* Correspondence: richard.anderson@ed.ac.uk
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Germline stem cells (GSCs) are a unique cell population
committed to producing gametes for the propagation of
the species. The concept of a GSC most likely originates
from Regaud [1,2], whose work on spermatogenesis was
published over a century ago. He postulated that, in
order for sperm production to occur, a population of
self-renewing cells must be present in the testis which
could produce differentiated progeny. It is now well
established that these cells, now known as spermatogon-
ial stem cells, contribute to spermatogenesis in adult-
hood in the males of all species studied [3]. Research on
the existence of a female counterpart, an ovarian GSC
that is able to undergo postnatal neo-oogenesis and thus
contribute to oocyte production in adulthood, has re-
vealed a more complicated picture. Although female
GSCs (fGSCs) appear to have a role in oogenesis
throughout reproductive life in some non-mammalian
species, these examples appear to be relatively rare
across the phyla of the animal kingdom [4], and the
presence of fGSCs in mammals has been greatly de-
bated. Indeed, the prevailing view is that female mam-
mals are born with a finite stock of mature oocytes that
become exhausted with aging, a hypothesis first sug-
gested by the 19th century embryologist Waldeyer [5].
General opinion changed at the beginning of the 20th
century when the prevailing belief was in favor of neo-
oogenesis in adulthood [6] until an influential article by
Zuckerman [7] in 1951 reported no evidence that new
oocytes are formed once a female is born, and the idea
of a fixed ovarian reserve in mammals has been a central
dogma in the field since. However, since 2004, a growing
number of researchers have found cause to question this
doctrine. The debate was reignited with the proposition
[8], and subsequent isolation [9-13], of purported fGSCs
(also known as oogonial stem cells, or OSCs).
in the adult mammalian ovary has yet to be determined.
Development and maturation of an oocyte entail a com-
plex and multifaceted process which has to be tightly
regulated in order for the oocyte to be competent for
fertilization. This includes bidirectional communicationLtd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
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precise timing of cessation and resumption of meiosis,
and correct genomic imprinting (reviewed last year by Li
and Albertini [14] and Anckaert and colleagues [15]).
Imprinting involves epigenetic alterations of the parental
alleles by DNA methylation and determines whether the
maternal or paternal gene will be expressed in the em-
bryo. Incorrect imprinting can lead to conditions such
as Angelman and Prader-Willi syndromes. Therefore, fu-
ture research involving the culture of oocytes derived
from purported adult mammalian fGSCs will have to en-
sure that these processes are intact for these cells to be
useful in clinical practice. This review will examine the
existence of OSCs in various species, consider where re-
search in the field is heading, and assess the therapeutic
potential of such cells.
Ovarian germline stem cells in non-mammalian species
and prosimian primates
There are several animals in which fGSCs actively re-
plenish the ovarian reserve postnatally. fGSCs in ‘lower’
invertebrates have been extensively studied in the fruit
fly, Drosophila [4]. In this species, a few primordial germ
cells (PGCs) are effectively ‘segregated’ in a special germ
cell niche at the tip of each ovariole (16 to 18 tubes that
make up the ovary) prenatally [16]. The environment
within this niche, in contrast to environments elsewhere
in the ovary, prevents the PGCs from differentiating,
and these undifferentiated cells subsequently become
fGSCs [17]. Postnatally, this niche controls the division
of fGSCs and the production of new oocytes, therefore
providing a continuous supply of germ cells throughout
reproductive life.
fGSCs have also been reported in teleost fish, includ-
ing the medaka (Oryzias latipes) [18] and zebrafish (Da-
nio rerio) [19]. As in Drosophila, medaka have a germ
cell niche, called the germinal cradle, situated in the
ovarian cords [18]. Within this area reside mitotic cells
that have the characteristics of fGSCs and that continu-
ously supply the ovary with new oocytes. Furthermore,
zebrafish possess a distinct zone on the ovarian surface
to which germ cells are confined, and this may also be
analogous to the Drosophila germ cell niche [19], sug-
gesting evolutionary conservation across animal phyla.
Oogenesis throughout reproductive life may be neces-
sary for the huge numbers of eggs produced during the
fish and fly life span and appears more similar to sperm-
atogenesis than the restrictive processes of oogenesis
and associated follicle development in higher mammals.
Although prior to 2004 it was widely believed that the
vast majority of adult mammals lack fGSCs, a few excep-
tions had been described. The adult ovaries of two mem-
bers of the loris family, which are prosimians related to
the lemur, have been reported to possess mitoticallyactive germ cells located within ‘nests’ in the ovarian
cortex [20-22]. It has not been proven, however, that
these cells, found in a slow loris (Nycticebus coucang)
and a slender loris (Loris tardigradus lydekkerianus), are
actually capable of undergoing folliculogenesis and pro-
ducing mature oocytes.
If fGSCs can be identified in such animals, why would
they not be present in the ovaries of the vast majority of
adult female mammals? Zuckerman himself was actually
an advocate for neo-oogenesis until his convictions were
changed by his extensive review of the literature [23], in
which he stated: ‘None of the experimental and quantita-
tive evidence which we have considered thus supports
the view that oogenesis occurs in the adult ovary, and
much of it bears very clearly against the proposition’ [7].
Lack of evidence is not definitive, and proving that a
cell does not exist is difficult, especially if they are a
scarce population. So what is the evidence for the exist-
ence of fGSCs in adult mammals?
Ovarian germline stem cells in mammals
The discovery of purported fGSCs in adult mice oc-
curred during an investigation of oocyte atresia and its
role in follicular dynamics, when an apparent mathemat-
ical anomaly was observed. Johnson and colleagues [8]
reported that follicular atresia was occurring at a rate
such that the adult mouse should exhaust her ovarian
reserve well before the age that it in fact occurs. This
implied that the follicle pool must be replenished in
adulthood by neo-oogenesis in order to sustain the re-
productive life of the mouse, and considering the germ
cell dynamics model of Faddy and colleagues [24], the
authors suggested that the adult mouse has to make 77
new primordial follicles a day. On further investigation,
a rare population of mitotically active ovoid cells in the
ovarian surface epithelium (OSE), which expressed the
germ cell-specific protein mouse vasa homolog (MVH),
was identified. Furthermore, when small pieces of wild-
type ovarian cortex were transplanted onto the ovaries
of transgenic mice that ubiquitously expressed green
fluorescent protein (GFP) for 3 to 4 weeks, GFP-positive
oocytes surrounded by wild-type somatic cells were
found within the wild-type graft. These results per-
suaded the authors that new oocytes must continue to
be produced throughout reproductive life in mice and
that the proliferating cells in the OSE may be putative
fGSCs and therefore the source of the ongoing
oogenesis.
The article by Johnson and colleagues was met with
widespread criticism, and subsequent work from the
Tilly group, who suggested that the source of these
fGSCs was the bone marrow and peripheral blood [25],
was even more controversial [26,27]. However, Zou and
colleagues [9] took a step forward when they reported
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ically activated cell sorting technique, the authors iso-
lated putative fGSCs measuring 12 to 20 μm in diameter
by using an antibody against either DDX4 (DEAD box
polypeptide 4; also known as vasa or MVH) or IFITM3
(interferon-induced transmembrane protein 3; also
known as fragilis) [9,11]. These cells expressed both
pluripotency and germ cell markers, had a normal
karyotype, and were maternally imprinted. Evidence of
their capacity to undergo oogenesis was provided when
GFP-expressing fGSCs were transplanted into sterilized
mice, with GFP-positive offspring being produced. These
findings in adult mice were supported by subsequent ar-
ticles by Pacchiarotti and colleagues [10] and Hu and
colleagues [12], who reported isolation of putative fGSCs
by using different techniques, though with limited dem-
onstration of oocyte-like competence. The first, and
only, published evidence of the existence of these cells
in humans was provided by the Tilly group in 2012 [13].
White and colleagues [13] developed a fluorescence-
activated cell sorting protocol that consistently isolated
fGSCs, which the authors named OSCs, from both adult
mice and humans. Measuring 5 to 8 μm, the cells were
smaller than those isolated by Zou and colleagues [9]
but expressed similar germ cell markers. The reason
these cells have not been detected in the past may be ex-
plained by the fact that White and colleagues [13] esti-
mated that the OSC population makes up only 0.014 %
± 0.002 % of the mouse ovary. The authors noted spon-
taneous production of oocyte-like cells from fGSCs in
in vitro culture (also observed by Pacchiarotti and col-
leagues [10]); these cells showed expression of oocyte-
specific and meiotic markers. Finally, by injecting GFP-
expressing fGSCs into non-GFP ovarian cortex and
xenotransplanting the tissue into mice, the authors re-
ported that primordial follicles comprising a GFP-
positive oocyte and wild-type granulosa cells could be
seen on removal of the graft.
In addition to these putative fGSCs, another popula-
tion of ovarian stem cells that reportedly differentiate
into oocytes has been isolated from the OSE [28-30].
These cells, named very small embryonic-like (VSEL)
stem cells, are cultured from OSE scrapings, are smaller
than the fGSCs discussed above, and differ in morph-
ology from those reported by White and colleagues [13].
The cells express a number of stem cell markers, includ-
ing SSEA-4, and spontaneously generate large, oocyte-
like cells in culture. Interestingly, Parte and colleagues
[29] also isolated a second putative ovarian stem cell
population, slightly larger in size than the VSEL stem
cells and perhaps more analogous to fGSCs. They postu-
lated that the VSEL stem cells are, in fact, the precursors
of these larger cells, which may be tissue-committed
ovarian stem cells [29]. To date, VSEL stem cells havebeen reported in adult mice, rabbits, sheep, marmoset
monkeys, and humans [28,29], including postmeno-
pausal women and women with premature ovarian in-
sufficiency [31]. VSEL stem cells from the OSE would
appear to be distinct from fGSCs; however, the existence
of VSEL stem cells, much like that of fGSCs, has also
been controversial [32].
More recent evidence for the existence of mammalian
fGSCs has been published by a Mexican group working
with three species of phyllostomid bats [33]. The use of
these species of bats is especially pertinent because they
share some reproductive similarities with primates, both
anatomically and with respect to ovulation patterns. For
example, Glossophaga soricina are polyoestrous mono-
ovulates with menstrual cycles of 22 to 26 days, includ-
ing a luteal phase and periodic endometrial shedding
[34]. Antonio-Rubio and colleagues [33] demonstrated
that the ovaries of Artibeus jamaicensis, Glossophaga sori-
cine, and Sturnira lilium are polarized, with a medullary
region containing developing follicles and a cortical region
containing both primordial follicles and a population of
cells which looked similar to germ cells histologically.
These cells, when analyzed with immunofluorescence,
expressed proliferation, pluripotency, and early germline
markers, including phosphorylated histone H3, POU5F1,
DDX4, and IFITM3, and were termed adult cortical germ
cells (ACGCs). The authors thus postulated that ACGCs
may be involved in adult neo-oogenesis in these species,
although, as with the loris species mentioned previously,
this was not demonstrated in this study.
In addition to this emergent body of proof, there is in-
direct evidence to support neo-oogenesis in adult female
mammals. Work on rhesus monkey ovaries in the 1950s
demonstrated findings similar to those of Johnson and
colleagues [8] in the mouse, with the observed rates of
follicular atresia predicting that monkey ovarian reserve
should be depleted within 2 years [35]. The author cal-
culated that the maximum life span of an oocyte was
2 years, and therefore the data suggested that the new
oocytes must be continually produced throughout repro-
ductive life. Mathematical modeling has provided con-
flicting data, and both Bristol-Gould and colleagues [36]
and Wallace and Kelsey [37] found that the ‘germline
stem cell model’ did not fit follicular kinetics data in ei-
ther mice [36] or humans [37]. Conversely, Kerr and col-
leagues [38] have published data in support of postnatal
oogenesis. Although they did not find evidence of GSCs,
the authors demonstrated that the mean number of
primordial follicles in mice did not decline between days
7 and 100 of age, leading them to surmise that there is a
mechanism by which postnatal neo-folliculogenesis sus-
tains the follicular pool.
Further indirect evidence has come from lineage tracing,
although this has also provided conflicting evidence; some
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been unable to disprove that postnatal neo-oogenesis ex-
ists [39,40]. Lei and Spradling [39] have reported that
primordial follicles are very stable, with no evidence of
high rates of turnover, therefore suggesting that the pool
is sufficient to sustain fertility without the requirement of
fGSCs. In contrast, by examining the accumulation of
microsatellite mutations in mice, Reizel and colleagues
[40] found that oocyte ‘depth’ increased with age; in other
words, the older the mouse, the more mitotic divisions
the oocyte has undergone. If neo-oogenesis were not oc-
curring postnatally, then depth should be stable through-
out life and independent of any interventions; however,
depth was also shown to increase after ovariectomy and
this would indicate neo-oogenesis [41]. The ‘production-
line hypothesis’ of Henderson and Edwards [42] may go
some way to explaining this observation; however, the for-
mation of new oocytes after birth is a possible alternative
explanation. The findings of Lei and Spradling have also
been refuted by Bhartiya and colleagues [43], who ob-
served germ cell ‘cysts’ in adult mice and sheep which, the
authors believe, reflect clonal expansion of stem cells
within the ovary.
Germline stem cell aging
If ovaries are capable of producing new oocytes during
adulthood, then the obvious question is: why do women
go through menopause? It has traditionally been be-
lieved that women enter menopause when their finite
supply of oocytes has been exhausted; however, if neo-
oogenesis does indeed exist, then the rate of new oocyte
production must lessen with age in order for menopause
to occur. There may be two potential underlying mecha-
nisms: failure of the fGSCs to form oocytes or failure of
the somatic environment to support oocyte development
(or both). It is possible that fGSCs, like many other cells,
undergo an aging process and thus lose their capacity to
regenerate and differentiate. In Drosophila, there is a re-
duction in oocyte production with age, associated with
declining rates of fGSC division and increased apoptosis
of developing oocytes [44]. Furthermore, an age-
dependent deterioration in germ cell niche signaling
may affect the ability of fGSCs to regenerate [44]. Sev-
eral putative causative mechanisms for these age-related
changes have been proposed, including a decrease in
bone morphogenetic protein (BMP) production by the
germ cell niche, a reduction in GSC-niche cell adhesion
via E-cadherin, and an increase in harmful reactive oxy-
gen species [45]. Manipulation of all of these factors has
been shown to increase fGSC life span [45].
It is likely that mammalian aging can also be attrib-
uted, at least partly, to age-related stem cell senescence,
and hematopoietic, neural, and muscle stem cell func-
tion all demonstrate a decline in function (reviewed in[46]). With regard to ovarian GSCs, Pacchiarotti and
colleagues [10] found that the number of fGSCs they
were able to isolate from mouse ovaries diminished with
increasing age of the mouse. Furthermore, a study has
reported the presence of putative fGSCs in aged mice
that appear to undergo folliculogenesis only when trans-
planted back into a young mouse ovary, thus implying
that the surrounding ovarian environment may have a
role to play in the ability of fGSCs to sustain a woman’s
reproductive function [47]. Therefore, the idea that the
existence of menopause renders neo-oogenesis impos-
sible is not necessarily correct: the two phenomena may
co-exist. However, the key demonstration that fGSCs
contribute to the postnatal follicle pool and potentially
to fertility in a physiological context has not been made.
Although fGSCs may be isolatable from ovarian tissue
and potentially able to form oocytes within follicles after
various manipulations, this may occur only under ex-
perimental conditions and they may not have any rele-
vance to the normal processes of ovarian function.
Basic science uses for germline stem cells
The potential uses for fGSCs are numerous, particularly
in basic science but potentially even in clinical applica-
tions. With regard to the former, fGSCs provide an ex-
citing prospect as a germ cell model in order to study
the development and maturation of the oocyte. Park and
colleagues [48] have used adult mouse-derived fGSCs to
investigate the effect of BMP4. BMPs are a member of
the transforming growth factor-beta family of growth
factors with a critical role in PGC specification [49,50]
and have been shown to act on germ cells within the de-
veloping human ovary [51]. Treatment of fGSCs with
BMP4 increased both the rate of in vitro differentiation
into oocyte-like structures and the expression of genes
associated with the initiation of meiosis: muscle-segment
homeobox 1 (Msx1), Msx2, and stimulated by retinoic
acid gene 8 (Stra8) [48].
fGSCs have also been genetically manipulated to pro-
duce transgenic mice. Zhang and colleagues [52] trans-
fected female adult mouse GSCs with recombinant
viruses containing vectors for different genes, including
GFP. When transplanted into sterilized mice and mated
with wild-type male mice, offspring heterozygous for the
transfected genes were produced. Using a liposome-
mediated transfection, the same group was also able to
create a knockout mouse to investigate the role of the
gene Oocyte-G1 [52]. The ability to produce transgenic
animals in this way could be an excellent tool for repro-
ductive biologists in the future.
Therapeutic uses for germline stem cells
There is no doubt that if fGSCs can be shown to develop
into mature, competent, correctly imprinted oocytes
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owing to technical and regulatory issues, it may be a
long time before this potential can be fulfilled. For ex-
ample, in the UK, research into whether fGSC-derived
oocytes would be capable of fertilization and develop-
ment into a blastocyst would be possible only with the
approval of the Human Fertilization and Embryology
Authority. Nevertheless, fGSCs may have a role in both
fertility preservation and the reversal of reproductive
senescence. With regard the former, it is conceivable
that fGSCs could be used as a fertility preservation
strategy for women who require gonadotoxic treatment
for cancer that may render them infertile. A sample of
ovarian cortex could be taken prior to commencing
treatment, and fGSCs could be isolated and cryopre-
served for future use. The fGSCs, when required, could
subsequently be injected back into a woman’s ovaries
where they could undergo neo-folliculogenesis, or they
could be cultured in vitro in ovarian cortex to a mature
oocyte stage and resultant oocytes used in in vitro
fertilization (IVF). The benefits of this approach are
twofold: firstly, taking ovarian cortex samples would not
require life-saving treatment to be delayed in contrast
to the ovarian superovulation regimens required for
oocyte and embryo cryopreservation; secondly, many
more new follicles and oocytes could be achieved from
fGSCs than would be present in cryopreserved tissue or
from ovarian stimulation.
Women with age-related infertility or premature ovar-
ian insufficiency may also benefit from fGSCs. ‘Social’
oocyte storage is becoming increasingly sought by
women who are anxious about how much longer their
ovarian reserve will last. However, this is an expensive
endeavor, is not without health risks, and may result in
only a small number of oocytes being cryopreserved. As
mentioned previously, putative fGSCs have been re-
ported in aged mice [47]; therefore, it is not impossible
that women who are perimenopausal, prematurely or
not, may have a very small number of these cells resid-
ing in their ovaries. The prospect of these cells growing
into oocytes in the aged stromal environment is less cer-
tain; however, they may be able to be used in IVF. The
idea of ‘reversing’ the reproductive clock and thereby
avoiding the detrimental health effects and climacteric
symptoms of menopause is appealing to some; however,
the aging ovarian milieu may also restrict the use of
fGSCs to this end. In summary, such clinical applica-
tions are currently aspirational but worthy of further
investigation.
Germline stem cells – the future
The field of reproductive biology remains very skeptical
of the idea that female mammalian GSCs exist and par-
ticularly that they have any physiological role in normalovarian function. Further demonstration of their isola-
tion and in vitro characteristics from a range of species
is needed as a first step. The potential for fGSCs to
differentiate into daughter cells that become mature oo-
cytes in an in vivo environment remains to be demon-
strated. Given the apparent scarcity of fGSCs in the
female mouse ovary, this may prove difficult to demon-
strate. For those groups who have already isolated puta-
tive fGSCs, the essential next steps are investigating the
conditions under which these cells will develop into oo-
cytes that are capable of fertilization and thus exploring
their potential as gametes. For fGSCs to be used in a
clinical context, a complete in vitro culture system will
need to be developed. In this regard, we are currently
investigating whether fGSCs can be grown into a ma-
ture oocyte by using a multi-step serum-free culture
system that we have already shown promotes healthy
follicular growth in bovine and human ovarian cortex
[53-55].
Conclusions
The reported existence of female mammalian GSCs has
stimulated much interest among reproductive biologists,
many of whom are yet to be convinced that these cells
are a real entity. However, there are now a growing
number of reports of their isolation and culture, and
strides are being taken to investigate their neo-oogenesis
capabilities. Whether these cells have a physiological role
has yet to be determined, and concerns remain that iso-
lated putative fGSCs have undergone in vitro transform-
ation in order to form oocytes; yet if their potential can
be harnessed, they may contribute greatly to our under-
standing of oocyte development and may be of import-
ant clinical relevance.
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